|
PROSPECTUS SUPPLEMENT NO. 5 (To base shelf prospectus dated August 11, 2003) |
Filed Pursuant to General Instruction II.L. of Form F-10; File No. 333-107361 |
Fairfax Financial Holdings Limited
US$200,000,000 Aggregate Principal Amount of
This document supplements our base shelf prospectus dated August 11, 2003, as supplemented October 6, 2003, October 31, 2003, December 19, 2003 and February 17, 2004, relating to the resale of up to US$200,000,000 aggregate principal amount of debentures and the subordinate voting shares issuable upon conversion, redemption, purchase or maturity thereof by certain selling securityholders, each an Electing Holder, named in Schedule A to this prospectus supplement.
You should read this prospectus supplement in conjunction with the base shelf prospectus. This prospectus supplement updates certain information in the base shelf prospectus and, accordingly, to the extent inconsistent, the information in this prospectus supplement supersedes the information contained in the base shelf prospectus.
The debentures and the subordinate voting shares issuable upon conversion, redemption, purchase or maturity thereof may be offered in negotiated transactions or otherwise, at varying prices determined at the time of the sale or at negotiated prices. In addition, the subordinate voting shares may be offered from time to time through ordinary brokerage transactions on the New York Stock Exchange. See “Plan of Distribution” in the base shelf prospectus.
Investing in the debentures and the subordinate voting shares issuable upon their conversion involves risks.
See the “Risk Factors” section beginning on page 2 of the base shelf prospectus.
We are permitted to prepare this prospectus supplement and the base shelf prospectus in accordance with Canadian disclosure requirements, which are different from those of the United States. We prepare our financial statements in accordance with Canadian generally accepted accounting principles, and are subject to Canadian auditing and auditor independence standards. As a result, they may be not be comparable to financial statements of United States companies.
Owning debentures or subordinate voting shares may subject you to tax consequences both in the United States and Canada. This prospectus supplement may not describe these tax consequences fully. You should read the tax discussion under “Certain Income Tax Considerations” in the base shelf prospectus.
Your ability to enforce civil liabilities under the United States federal securities laws may be affected adversely because we are incorporated in Canada, our officers and directors and the experts named in the base shelf prospectus are Canadian residents, and many of our assets are located outside the United States.
NEITHER THE SECURITIES AND EXCHANGE COMMISSION NOR ANY STATE SECURITIES REGULATOR HAS APPROVED OR DISAPPROVED OF THESE SECURITIES OR DETERMINED IF THIS PROSPECTUS SUPPLEMENT OR THE BASE SHELF PROSPECTUS IS TRUTHFUL OR COMPLETE. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.
The date of this prospectus supplement is March 9, 2004.
WHERE YOU CAN FIND MORE INFORMATION ABOUT FAIRFAX
The following documents, filed with the Ontario Securities Commission (the “OSC”) under the Securities Act (Ontario) are specifically incorporated by reference into and form an integral part of the base shelf prospectus, as supplemented, which we refer to as the prospectus:
| (a) | our Renewal Annual Information Form for the year ended December 31, 2002, dated May 15, 2003; | |
| (b) | our audited consolidated financial statements and the notes thereto as at December 31, 2003 and 2002, and for each of the years in the three year period ended December 31, 2003 together with the auditors’ report thereon contained in our 2003 Annual Report; and | |
| (c) | our Management’s Discussion and Analysis for the year ended December 31, 2003; |
Any document of the type referred to in the preceding paragraphs and any interim consolidated financial statements and the accompanying management’s discussion and analysis, management information circulars (except as provided under applicable securities laws) and material change reports (excluding confidential material change reports) subsequently filed by us with the OSC after the date of this prospectus supplement and prior to the termination of the distribution of the debentures and subordinate voting shares under this prospectus supplement shall be deemed to be incorporated by reference in this prospectus.
Any statement contained in a document incorporated or deemed to be incorporated by reference in this prospectus shall be deemed to be modified or superseded, for the purposes of this prospectus, to the extent that a statement contained herein or therein, or any other subsequently filed document which also is or is deemed to be incorporated by reference herein or therein, modifies or supercedes that statement. The modifying or superseding statement need not state that it has modified or superseded a prior statement or include any other information set forth in the document that it modifies or supersedes. The making of a modifying or superseding statement shall not be deemed an admission for any purposes that the modified or superseded statement, when made, constituted a misrepresentation, an untrue statement of a material fact or an omission to state a material fact that is required to be stated or that is necessary to make a statement not misleading in light of the circumstances in which it was made. Any statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this prospectus.
Upon a new annual information form and new annual comparative consolidated financial statements being filed by us with, and where required, accepted by, the applicable securities regulatory authorities during the currency of this prospectus, the previous annual information form, the previous annual comparative consolidated financial statements and the accompanying management’s discussion and analysis, all interim consolidated financial statements and the accompanying management’s discussion and analysis, information circulars and material change reports filed prior to the commencement of our then current fiscal year in which our new annual information form is filed, will be deemed no longer to be incorporated into this prospectus for purposes of future offers and sales of the securities under this prospectus. Upon interim consolidated financial statements and the accompanying management’s discussion and analysis being filed by us with the applicable securities regulatory authorities during the currency of this prospectus, all interim consolidated financial statements and the accompanying management’s discussion and analysis filed prior to the new interim consolidated financial statements will be deemed no longer to be incorporated into this prospectus for purposes of future offers and sales of securities under this prospectus.
Information has been incorporated in this prospectus from documents filed with the OSC. Copies of documents incorporated herein or therein by reference may be obtained on request without charge from Bradley P. Martin, Vice President and Corporate Secretary of Fairfax, at Suite 800, 95 Wellington Street West, Toronto, Ontario, M5J 2N7. Copies of documents that we have filed with the OSC may be obtained over the Internet at the Canadian Securities Administrators’ website at www.sedar.com.
We are subject to the informational requirements of the Securities Exchange Act of 1934, as amended, and in accordance therewith file or furnish reports and other information with or to the SEC.
S-2
EARNINGS COVERAGE RATIO
The following consolidated financial ratios are calculated for the twelve-month period ended December 31, 2003. The pro forma ratio gives effect as of the beginning of the period to:
| • | the issuance of US$300.0 million 10.375% senior notes due 2013 by Crum & Forster on June 5, 2003, the receipt of US$217.9 million net proceeds therefrom (after expenses of issue and the deposit of US$63.1 million in an interest escrow account to fund the first four interest payments) and the application of $63.5 million of such net proceeds to repay bank indebtedness; | |
| • | the issuance of US$200.0 million aggregate principal amount of the debentures and the receipt of the net proceeds therefrom; | |
| • | the issuance of US$225.0 million 7.65% senior notes due 2013 by OdysseyRe on October 31, 2003 and November 18, 2003 and the receipt of the net proceeds therefrom; and | |
| • | the repayment of US$50.0 million 7.49% senior notes due 2006 by OdysseyRe on October 31, 2003. |
| Twelve Months | ||||||||
| Ended | ||||||||
| December 31, 2003 | ||||||||
| Actual | Pro Forma | |||||||
|
Earnings coverage(1)
|
4.6x | 3.8x | ||||||
| (1) | Earnings coverage is equal to net income (excluding unusual items before interest expense and income taxes divided by interest expense on all debt). |
Our interest expense amounted to approximately US$146.3 million for the twelve-month period ended December 31, 2003. Our earnings before interest expense and income taxes for the twelve-month period ended December 31, 2003 was approximately US$673.8 million, which is 4.6 times our interest expense for the period.
After giving effect to the three debt issuances and the debt repayment described above as if they had occurred at the beginning of the period, our interest expense would have amounted to approximately US$176.1 million for the twelve-month period ended December 31, 2003. After giving effect to the three debt issuances and the debt repayment described above as if they had occurred at the beginning of the period, our earnings before interest expense and income taxes for the twelve-month period ended December 31, 2003 would have been approximately US$677.6 million, which would have been 3.8 times our interest expense for the period.
S-3
SCHEDULE A
ELECTING HOLDERS
The debentures originally were issued by us and sold by Banc of America Securities LLC, Ferris, Baker Watts Incorporated and BNY Capital Markets, Inc., as the initial purchasers, in transactions exempt from the registration requirements of the Securities Act of 1933, as amended, to persons reasonably believed by the initial purchasers to be qualified institutional buyers. The Electing Holders named below, including their transferees, pledgees or donees or their successors, may from time to time offer and sell any or all of the debentures and the subordinate voting shares conversion, redemption, purchase or maturity thereof pursuant to this prospectus supplement. The Electing Holders may offer all, some or none of the debentures and the subordinate voting shares issuable upon conversion, redemption, purchase or maturity thereof.
The table below sets forth the name of each Electing Holder, the principal amount of debentures that may be offered by each Electing Holder under this prospectus and the number of subordinate voting shares into which the debentures are convertible upon conversion, redemption, purchase or maturity thereof. The information is based on information provided to us by or on behalf of the Electing Holders on or prior to March 8, 2004. The Electing Holders identified below may have sold, transferred or otherwise disposed of all or a portion of their debentures or subordinate voting shares since the date on which they provided this information in transactions exempt from the registration requirements of the Securities Act of 1933, as amended. Information about the Electing Holders may change from time to time. Any changed information will be set forth in prospectus supplements or post-effective amendments, as required.
Because the Electing Holders may offer all or some portion of the debentures or the subordinate voting shares issuable upon conversion, redemption, purchase or maturity thereof, we cannot estimate the amount of debentures or subordinate voting shares that may be held by the Electing Holders upon the conversion, redemption, purchase or maturity thereof, upon completion of any sales. For information on the procedure for sales by selling securityholders, read the disclosure under the heading “Plan of Distribution” in the base shelf prospectus.
| Principal Amount of | Number of | |||||||
| Debentures Beneficially Owned | Subordinate Voting Shares | |||||||
| Name of Electing Holder | and Offered Hereby* | Beneficially Owned** | ||||||
|
Amaranth L.L.C.
|
US$ | 63,050,000 | 296,694 | |||||
|
Argent Classic Convertible Arbitrage Fund
(Bermuda) Ltd.
|
2,000,000 | 9,411 | ||||||
|
Banc of America Securities LLC
|
655,000 | 3,082 | ||||||
|
Chrysler Corporation Master Retirement Trust
|
1,895,000 | 8,917 | ||||||
|
CQS Convertible & Quantitative Strategies
Master Fund Limited
|
12,500,000 | 58,821 | ||||||
|
D.E. Shaw Investment Group, L.P.
|
400,000 | 1,882 | ||||||
|
D.E. Shaw Valence Portfolios, L.P.
|
1,600,000 | 7,529 | ||||||
|
DBAG London
|
18,750,000 | 88,231 | ||||||
|
Deephaven Domestic Convertible Trading Ltd.
|
3,933,000 | 18,507 | ||||||
|
Delta Air Lines Master Trust — CV
|
835,000 | 3,929 | ||||||
|
Delta Pilots Disability and Survivorship
Trust — CV
|
375,000 | 1,764 | ||||||
|
Jersey (IMA) Ltd.
|
2,500,000 | 11,764 | ||||||
|
LibertyView Credit Opportunities Fund L.P.
|
3,000,000 | 14,117 | ||||||
|
LibertyView Funds L.P.
|
5,500,000 | 25,881 | ||||||
|
Marathon Global Convertible Master Fund Ltd.
|
18,000,000 | 84,702 | ||||||
|
Microsoft Corporation
|
1,415,000 | 6,658 | ||||||
|
MLQA Convertible Securities Arbitrage
|
2,500,000 | 11,764 | ||||||
|
Motion Picture Industry Health Plan —
Active Member Fund
|
195,000 | 917 | ||||||
|
Motion Picture Industry Health Plan —
Retiree Member Fund
|
120,000 | 564 | ||||||
|
OCM Convertible Trust
|
1,850,000 | 8,705 | ||||||
|
Qwest Occupational Health Trust
|
250,000 | 1,176 | ||||||
|
Sphinx Convertible Arbitrage Fund SPC
|
67,000 | 315 | ||||||
|
State Employees’ Retirement Fund of the
State of Delaware
|
825,000 | 3,882 | ||||||
|
Sunrise Partners Limited Partnership
|
8,450,000 | 39,763 | ||||||
|
Vanguard Convertible Securities Fund,
Inc.
|
5,865,000 | 27,598 | ||||||
|
Zazove Convertible Arbitrage Fund,
L.P.
|
2,000,000 | 9,411 | ||||||
|
Total
|
US$ | 158,530,000 | 745,984 | |||||
| * | This includes all of the debentures beneficially owned by the Electing Holders. |
| ** | Assumes conversion of all of the Electing Holder’s debentures at the initial conversion ratio of 4.7057 subordinate voting shares per US$1,000 principal amount of debentures and a cash payment in lieu of fractional shares. The conversion ratio is subject to adjustment as described under “Description of the Debentures — Conversion Rights — Conversion Rate Adjustments” in the base shelf prospectus. As a result, the number of subordinate voting shares may increase or decrease in the future. |
S-4